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Cultured endothelial cells (EC) from human umbilical vein were incubated with [UJ”C]arachidonic acid 
(AA) followed by a challenge with thrombin (2 units/ml) or calcium ionophore A23187 (5 PM) for 0.5-10 
min at 37°C. In both cases, AA was rapidly liberated from phospholipids and converted into prostaglandin 
I, (PGIJ, as determined by the radioactivity of the stable derivative bketo-PGF,,. Maximal liberation of 
AA and synthesis of PGI, were~achieved within 2 min, but the two compounds first accumulated in EC 
prior to their release into supernatants. This &ding, which was never reported before, raises the question 
of the mechanism of AA and PG release through the cell membranes and offers a convenient model to inves- 
tigate this still obscure process. 
Endotheliul cell Prostaglandin Prostacyclin 
1. INTRODUCTION 
Among various factors involved in the anti- 
thrombotic function of endothelial cells (EC), the 
secretion of prostacyclin or prost~~n~n 12 
(PGIs), an unstable but powerful PG able to in- 
hibit platelet aggregation and to evoke vasodila- 
tion, might play a crucial role [l-3]. As for other 
oxygenated derivatives of AA, PGI2 biosynthesis 
requires a previous liberation from phospholipids 
through the action of phospholipases [3-51. In 
previous studies dealing with this problem, we 
showed that ph~phat~ylcholi~e might represent 
the major phospholipid involved in AA release 
upon THR and calcium ionophore A23187 stimul- 
ation of EC [6,7]. These results were obtained by 
a previous, labelling of EC lipids with [‘HIAA, 
followed by analysis of supernatant and cell lipids 
Abbrevjotio~~ EC, ~dot~li~ cells; PG, prosteglau- 
din; AA, arachidonic acid; ASA, acetylsalicylic acid 
(aspirin); TNR, thrombin 
Arachidonic acid Secretion Thrombin 
by thin-layer chromatography (TLC) after trigger- 
ing EC with THR or A23187 for 10 min. 
In more recent investigations dealing with the 
time course of AA liberation using a “C-labelled 
precursor, we observed that 6-keto-PGFr,, the 
stable derivative of PGI2, could be detected in EC 
soon after THR or A23187 challenge, its ap- 
pearance in cell supematants occurring only secon- 
darily. This prompted us to investigate in more 
detail this sequence of events. The present study 
describes a two-step process of PO12 secretion in- 
volving accumulation inside the cells prior to a 
slow release. So this unexpected finding offers a 
convenient model to study the mechanism by 
which PC crosses the membrane of parent cells 
after biosynthesis. 
2. MATERIALS AND METHODS 
2.1. Materials 
All materials and media used for cell culture 
were purchased from Seromed (Munich, FRG). 
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[U-“C]AA was from N.E.N. (Dreieich, FRG). 
Calcium ionophore A23 187 was obtained from 
Boehringer Mannheim and human thrombin (3000 
NIH units/mg protein) was from Sigma (St. Louis, 
MO). Acetylsalicylic acid (lysin salt) was obtained 
from Egic laboratory (Amilly, France). 
2.2. Labeiling of EC 
EC from human umbilical veins were cultured 
essentially as in [6] using AB human serum and 
identified as EC using morphological and im- 
munological criteria [8]. 
For each experiment, 6 flasks of EC derived 
from the same cord were used after reaching con- 
fluence. After a 20-h incubation at 37°C in a 3% 
CO2 atmosphere with 5 ml growth medium con- 
taining 0.5 pCi [‘%JAA, the supernatant was 
removed and the cellular monolayer washed twice 
with 5 ml M199. 
2.3. Stimulation study 
The labelled cells, prepared as above, were in- 
cubated with 5 ml Ml99 containing 5 pM A23187 
dissolved in 0.05 ml dimethylsulfoxide or 10 units 
thrombin in 0.02 ml isotonic NaCl. In control ex- 
periments, only the solvent was added. In ex- 
periments dealing with the effect of ASA (0.1 
mM), the cells were previously incubated for 30 
min in the presence of the drug before adding 
A23187, thrombin or control solvent. Aliquots of 
the supernatants (0.1 ml) were taken off for 
radioactivity determination and the whole super- 
natant was collected, acidified to pH 4 by glacial 
acetic acid (0.1 ml) and immediately extracted 
twice with 2 vols ethyl acetate. The remaining cells 
were scrapped in 5 ml methanol containing 0.5 ml 
EDTA (0.2 M, pH 7.4). The cell lipids were ex- 
tracted as in [9] using acidified water (pH 4) in- 
stead of buffer. 
2.4. Lipid analysis 
Cell and supernatant lipids were separated by 
monodimensional TLC on silicagel 60 plates 
(Merck, Darmstadt) using the upper phase of a 
mixture of ethyl acetate : acetic acid : isooctane :
water (110 :20 : 50: 100, v/v). The various spots 
detected by autoradiography were scrapped into 
scintillation vials containing 10 ml Instagel (Pack- 
ard) and radioactivity was determined using an In- 
ter-technique spectrometer. 
3. RESULTS 
Fig.1 represents an autoradiogram of lipid ex- 
tracts from both EC and supernatants after TLC 
separation. Besides phospholipids, which were 
most abundant in cell extracts, several spots ap- 
peared upon cell stimulation with THR. Among 
these, phosphatidic acid and diglycerides were only 
detected in EC extracts, whereas 6-keto-PGFr,, 
PGFti, PGE2 (cycle-oxygenase products), hy- 
droxy-eicosanoic acids (lipoxygenase metabolites) 
[lo] and free AA were seen in both EC and super- 
natant extracts. As observed in [6,7], the 5 latter 
compounds displayed a maximal increase in 
lO-min supernatants, 6-keto-PGFr, and free AA 
being the major compounds. However, their 
Fig. 1. Thin-layer chromatography of radioactive com- 
pounds formed after thrombin stimulation of [“CIA& 
labelled EC. Cell lipids: lane A, control (unstimulatkd 
cells); lanes B,C, thrombin-stimulated cells after 2 min 
(I&) ,ahd 10 min (C). Supematant lipids: lane D, control 
(u~timulatecl ells); lanes l&F, thrombin-stimulated 
cells after 2 min (E) and 10 ,min (F). Numbers refer to the 
following compounds: 1,phospholipids; 2, phosphatidic 
a&W, 6-ketoPGFr,;,4, PGFa,; 5, PGEt; 6, hydroxy- 
eicosanoic acids; 7, AA; 8, diglycerides; 9, other neutral 
lipids. 
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presence in EC, especially after short incubation 
times, indicated that PGIz and liberated AA might 
accumulate in EC before releasing into the medium. 
To have further insight into this process, radio- 
active free AA and 6-keto-PGFi, were quantified 
in lipid extracts from both EC and supernatants 
after stimulation for different times with THR or 
A23187. As shown in fig.2A, THR stimulation 
evoked a rapid synthesis of PGI2, which became 
maximal already after 2 min. But until l-2 min, 
6-keto-PGFi, remained confined to the cell ex- 
tract, whereas a slow release process took place 
afterwards, leading to a 2-times higher amount of 
PGI2 in the medium after 10 min stimulation. 
When considering free AA, a similar pattern was 
observed (fig.;ZB), although some amounts of it 
were already present in EC before THR stimula- 
tion, in agreement with our previous data [6,7]. In 
this case, it must also be noted that the total 
amount of AA decreased slightly between 5 and 10 
min, probably indicating some reacylation into 
phospholipids. 
Almost identical results were also obtained for 
both compounds with A23187 (fig.3A,B), the only 
difference being a larger mobilization of AA by 
comparison with THR. 
Fig.4 and 5 illustrate the effect of acetylsalicylic 
acid (ASA) on PGIz and AA accumulation in the 
two compartments (cells and supernatants). Con- 
firming data of fig.2, 6-keto-PGFr, and AA were 
more abundant in EC than in supernatants after 1 
min stimulation, whereas the reverse was observed 
after 10 min. In all cases, pretreatment of EC with 
ASA suppressed completely the PGIz appearance 
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Fig.2. (A) Synthesis of PGIz upon thrombin stimulation 
(2 units/ml) of human EC. Values correspond to means 
f SE (4 experiments). (B) Liberation of free AA upon 
thrombin stimulation (2 units/ml) of human EC. Values 
correspond to means f SE (4 experiments). 
Fig.3. (A) Synthesis of PGI2 upon A23 187 stimulation (5 
PM) of human EC. Values correspond to means f SE 
(4 experiments). (B) Liberation of free AA upon A23187 
stimulation (5 PM) of human EC. Values correspond to 
means f SE (4 experiments). 
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Fig.4. Radioactivity changes of dketo-PGFr, and free 
AA cell associated or secreted upon thrombin 
stimulation without (0) or with ASA (0.1 mM) (m). 
Results are expressed as percentages of total 
radioactivity present in cells + supernatants, compared 
with unstimulated control cultures. 
in both cells and medium. In contrast, the amount 
of AA increased, especially in the cell extracts after 
short incubation periods. The lower effect of ASA 
on the amount of AA after 10 min might be ex- 
plained by a reacylation of the excess of AA not 
converted into PGI2. These results give further 
support to the identification of 6-keto-PGFr, in 
both supernatants and cell extracts. 
4. DISCUSSION 
PG and other oxygenated derivatives of AA are 
lipidic mediators able to transfer information bet- 
ween a parent cell and a target cell. For instance, 
the biological system used here involves EC, which 
can inhibit platelet function and evoke vasodila- 
tion through the release of the powerful PGI2 
[l-3]. AA liberation from phospholipids is 
thought to occur at the inside of the producing cell. 
Such a view is supported by the fact that AA 
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Fig.5. Radioactivity changes of 6-keto-PGFr, and free 
AA cell associated or secreted upon A23187 stimulation 
without (0) or with ASA (0.1 mM) (m). Results are ex- 
pressed as percentages of total radioactivity present in 
cells + supematants, compared with unstimulated con- 
trol cultures. 
availability to cycle-oxygenase and lipoxygenases 
is mostly regulated by phospholipase AZ. This 
calcium-dependent enzyme becomes activated 
through calcium mobilization to the cytoplasm 
upon specific cell stimulation by various agonists 
or calcium ionophores [3-7,111. This hypothesis 
also fits our previous observation that membrane 
phospholipid asymmetry retains around 95% of 
total AA at the inside of human platelets [12]. 
However, nothing is known about he mechan- 
ism allowing PG release from stimulated cells. 
Many studies dealing with PG synthesis were based 
on PG determination in the medium using, for in- 
stance, radioimmunoassays [131, whereas meta- 
bolic investigations often involved lipid extraction 
of the total medium, including cells and extracell- 
ular space [11,14-161. To our knowledge, this 
work brings the first observation that a clear 
dissociation exists between the process of in- 
tracellular PG biosynthesis and the process of 
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secretion. Indeed, 6-keto-PGFi,, the stable deri- 
vative of the major PG synthesized by EC, was 
identified in EC as an early product on the basis of 
its chromatographic behaviour as well as on the 
fact that its synthesis was completely suppressed by 
ASA treatment. Also, its release from cells was 
quite simultaneous with its appearance into super- 
natants. 
This finding might have three significant conse- 
quences: (i) from a practical point of view, it im- 
plies that PG determination in cell supernatants 
does not reflect the time course of PG synthesis, 
since the compounds could appear only secondari- 
ly in the cell medium; (ii) from a basic point of 
view, it raises the general question of the mechan- 
ism allowing lipid mediators to cross the cell mem- 
brane. As for free fatty acids, the question is still 
open as to whether a single diffusion/partition or 
a specific carrier-mediated process is involved in 
such a transport [17,18]. In this respect, EC could 
offer a convenient model for studies dealing with 
this transport mechanism. Comparison with other 
cell systems might also be very helpful in in- 
vestigating this problem (iii) from a pharmacolo- 
gical point of view, it implies that besides a 
modulation of the enzymes involved in the biosyn- 
thesis of PG and other parent compounds, drugs 
able to modify the release process might also prove 
useful in the field of inflammation or thrombosis. 
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